; (2) include understandable plain language, and include graphics and pictures when applicable, and be provided in a consistent, standardized format and color for all drug products, and not be promotional in tone or content, and contain at least— (A) the established name of the drug (or, if the drug is a biological product, the proper name of the biological product) and the national drug code for the drug; (B) indications for use approved by the Food and Drug Administration; (C) general directions for proper use; (D) contraindications, warnings, precautions, the most frequently occurring adverse reactions, and adverse reactions that are important for other reasons (such as because they are serious), especially with respect to certain subpopulations such as children, pregnant women, and the elderly; (E) measures patients may be able to take, if any, to reduce the side effects and risks of the drug; (F) information about when a patient should contact his or her health care professional; (G) instructions not to share medications, and, if applicable, key storage requirements and recommendations relating to proper disposal of any unused portion of the drug; (H) known clinically important interactions with other drugs, food, and other substances; (I) a statement of whether sufficient data are available concerning the use of the drug in specified subpopulations, such as women, pregnant women, lactating women, women and men of reproductive age, and pediatric, geriatric, racial, and ethnic minority groups; (J) the name of the manufacturer and a toll-free telephone number for consumers to contact the manufacturer of the drug; and (K) a current link to Form FDA 3500B for voluntary reporting for consumers of adverse events, product problems, and product use errors (or any successor form)